<DOC>
	<DOCNO>NCT01065051</DOCNO>
	<brief_summary>The aim study ass whether oral Riociguat affect leave ventricular contractility relaxation patient pulmonary hypertension associate leave ventricular systolic dysfunction</brief_summary>
	<brief_title>Hemodynamic Echocardiographic Assessment Riociguat Effects Myocardial Wall Contractility Relaxation Kinetics</brief_title>
	<detailed_description>Adverse event data cover Adverse event section .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Male female patient symptomatic pulmonary hypertension due leave ventricular systolic dysfunction despite standard heart failure therapy Types pulmonary hypertension group 2.1 Dana Point Classification</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Left ventricular dysfunction</keyword>
</DOC>